Comparative Effectiveness of 5 Smoking Cessation Pharmacotherapies in Primary Care Clinics

被引:111
作者
Smith, Stevens S. [1 ,2 ]
McCarthy, Danielle E. [3 ]
Japuntich, Sandra J. [1 ,2 ]
Christiansen, Bruce [1 ,2 ]
Piper, Megan E. [1 ,2 ]
Jorenby, Douglas E. [1 ,2 ]
Fraser, David L. [1 ,2 ]
Fiore, Michael C. [1 ,2 ]
Baker, Timothy B. [1 ,2 ]
Jackson, Thomas C. [1 ,2 ]
机构
[1] Univ Wisconsin, Ctr Tobacco Res & Intervent, Sch Med & Publ Hlth, Madison, WI 53711 USA
[2] Univ Wisconsin, Dept Med, Sch Med & Publ Hlth, Madison, WI 53711 USA
[3] Rutgers State Univ, Dept Psychol, Piscataway, NJ USA
基金
美国国家卫生研究院;
关键词
SUSTAINED-RELEASE BUPROPION; SELF-REPORTED SMOKING; NICOTINE PATCH; TRIAL; QUITLINE; VALIDITY; PLACEBO;
D O I
10.1001/archinternmed.2009.426
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Randomized efficacy clinical trials conducted in research settings may not accurately reflect the benefits of tobacco dependence treatments when used in real-world clinical settings. Effectiveness trials (eg, in primary care settings) are needed to estimate the benefits of cessation treatments in real-world use. Methods: A total of 1346 primary care patients attending routine appointments were recruited by medical assistants in 12 primary care clinics. Patients were randomly assigned to 5 active pharmacotherapies: 3 monotherapies (nicotine patch, nicotine lozenge, and bupropion hydrochloride sustained release [SR]) and 2 combination therapies (patch + lozenge and bupropion SR + lozenge). Patients were referred to a telephone quit line for cessation counseling. Primary outcomes included 7-day point prevalence abstinence at I week, 8 weeks, and 6 months after quitting and number of days to relapse. Results: Among 7128 eligible smokers (>= 10 cigarettes per day) attending routine primary care appointments, 1346 (18.9%) were enrolled in the study. Six-month abstinence rates for the 5 active pharmacotherapies were the following: bupropion SR, 16.8%; lozenge, 19.9%; patch, 17.7%; patch + lozenge, 26.9%; and bupropion SR + lozenge, 29.9%. Bupropion SR + lozenge was superior to all of the monotherapies (odds ratio, 0.46-0.56); patch + lozenge was superior to patch and bupropion monotherapies (odds ratio, 0.56 and 0.54, respectively). Conclusions: One in 5 smokers attending a routine primary care appointment was willing to make a serious quit attempt that included evidence-based counseling and medication. In this comparative effectiveness study of 5 tobacco dependence treatments, combination pharmacotherapy significantly increased abstinence compared with monotherapies. Provision of free cessation medications plus quit line counseling arranged in the primary care setting holds promise for assisting large numbers of smokers to quit.
引用
收藏
页码:2148 / 2155
页数:8
相关论文
共 28 条
[1]   Benefits of telephone care over primary care for smoking cessation - A randomized trial [J].
An, LC ;
Zhu, SH ;
Nelson, DB ;
Arikian, NJ ;
Nugent, S ;
Partin, MR ;
Joseph, AM .
ARCHIVES OF INTERNAL MEDICINE, 2006, 166 (05) :536-542
[2]  
Armour B. S., 2005, Morbidity and Mortality Weekly Report, V54, P625
[3]   The feasibility of connecting physician offices to a state-level tobacco quit line [J].
Bentz, CJ ;
Bayley, KB ;
Bonin, KE ;
Fleming, L ;
Hollis, JF ;
McAfee, T .
AMERICAN JOURNAL OF PREVENTIVE MEDICINE, 2006, 30 (01) :31-37
[4]   In-practice management versus quitline referral for enhancing smoking cessation in general practice: a cluster randomized trial [J].
Borland, Ron ;
Balmford, James ;
Bishop, Nicole ;
Segan, Catherine ;
Piterman, Leon ;
McKay-Brown, Lisa ;
Kirby, Catherine ;
Tasker, Caroline .
FAMILY PRACTICE, 2008, 25 (05) :382-389
[5]  
Burton S L, 2000, MMWR Morb Mortal Wkly Rep, V49, P665
[6]  
Centers for Disease Control and Prevention (CDC), 1993, MMWR Morb Mortal Wkly Rep, V42, P854
[7]   The association between patient-reported receipt of tobacco intervention at a primary care visit and smokers' satisfaction with their health care [J].
Conroy, MB ;
Majchrzak, NE ;
Regan, S ;
Silverman, CB ;
Schneider, LI ;
Rigotti, NA .
NICOTINE & TOBACCO RESEARCH, 2005, 7 :S29-S34
[8]   The timeline followback reports of psychoactive substance use by drug-abusing patients: Psychometric properties [J].
Fals-Stewart, W ;
O'Farrell, TJ ;
Freitas, TT ;
McFarlin, SK ;
Rutigliano, P .
JOURNAL OF CONSULTING AND CLINICAL PSYCHOLOGY, 2000, 68 (01) :134-144
[9]   Integrating smoking cessation treatment into primary care: an effectiveness study [J].
Fiore, MC ;
McCarthy, DE ;
Jackson, TC ;
Zehner, ME ;
Jorenby, DE ;
Mielke, M ;
Smith, SS ;
Guiliani, TA ;
Baker, TB .
PREVENTIVE MEDICINE, 2004, 38 (04) :412-420
[10]  
Fiore MC., 2008, TREATING TOBACCO USE